Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.
Peyre M, Zanello M, Mokhtari K, Boch AL, Capelle L, Carpentier A, Clemenceau S, Karachi C, Navarro S, Nouet A, Reina V, Valery CA, Sanson M, Cornu P, Kalamarides M. Peyre M, et al. Among authors: carpentier a. J Neurooncol. 2015 May;123(1):151-60. doi: 10.1007/s11060-015-1778-1. Epub 2015 Apr 17. J Neurooncol. 2015. PMID: 25894596
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.
Carpentier A, Laigle-Donadey F, Zohar S, Capelle L, Behin A, Tibi A, Martin-Duverneuil N, Sanson M, Lacomblez L, Taillibert S, Puybasset L, Van Effenterre R, Delattre JY, Carpentier AF. Carpentier A, et al. Among authors: carpentier af. Neuro Oncol. 2006 Jan;8(1):60-6. doi: 10.1215/S1522851705000475. Neuro Oncol. 2006. PMID: 16443949 Free PMC article. Clinical Trial.
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.
Carpentier A, Metellus P, Ursu R, Zohar S, Lafitte F, Barrié M, Meng Y, Richard M, Parizot C, Laigle-Donadey F, Gorochov G, Psimaras D, Sanson M, Tibi A, Chinot O, Carpentier AF. Carpentier A, et al. Among authors: carpentier af. Neuro Oncol. 2010 Apr;12(4):401-8. doi: 10.1093/neuonc/nop047. Epub 2010 Jan 25. Neuro Oncol. 2010. PMID: 20308317 Free PMC article. Clinical Trial.
Clinical trial of blood-brain barrier disruption by pulsed ultrasound.
Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, Karachi C, Leclercq D, Lafon C, Chapelon JY, Capelle L, Cornu P, Sanson M, Hoang-Xuan K, Delattre JY, Idbaih A. Carpentier A, et al. Sci Transl Med. 2016 Jun 15;8(343):343re2. doi: 10.1126/scitranslmed.aaf6086. Sci Transl Med. 2016. PMID: 27306666 Clinical Trial.
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study.
Ursu R, Carpentier A, Metellus P, Lubrano V, Laigle-Donadey F, Capelle L, Guyotat J, Langlois O, Bauchet L, Desseaux K, Tibi A, Chinot O, Lambert J, Carpentier AF. Ursu R, et al. Among authors: carpentier a, carpentier af. Eur J Cancer. 2017 Mar;73:30-37. doi: 10.1016/j.ejca.2016.12.003. Epub 2017 Jan 28. Eur J Cancer. 2017. PMID: 28142059 Clinical Trial.
Predictive factors of long-term outcomes of surgery for mesial temporal lobe epilepsy associated with hippocampal sclerosis.
Mathon B, Bielle F, Samson S, Plaisant O, Dupont S, Bertrand A, Miles R, Nguyen-Michel VH, Lambrecq V, Calderon-Garcidueñas AL, Duyckaerts C, Carpentier A, Baulac M, Cornu P, Adam C, Clemenceau S, Navarro V. Mathon B, et al. Among authors: carpentier a. Epilepsia. 2017 Aug;58(8):1473-1485. doi: 10.1111/epi.13831. Epub 2017 Jun 28. Epilepsia. 2017. PMID: 28656696
1,225 results